Episode 30: Dr. Matthew Miles & MS Research Australia

We have a lot to talk about in this podcast episode! First, a big announcement…the RealTalk MS Podcast has its own Amazon Alexa Skill! If you already own an Amazon Echo, Dot, or any Alexa-enabled device, you can access all sorts of convenient features for listening to RealTalk MS! (And if you don't yet have an Alexa-enabled device, this might be one more reason to get one!)

My guest on the podcast is Dr. Matthew Miles, the CEO of MS Research Australia, the largest non-profit organization dedicated to funding, coordinating, and advocating for MS research in Australia. We're talking with Matthew about some of the amazing research collaborations that MS Research Australia is driving in Australia and around the world. (NOTE: During our conversation, Dr. Miles references the MS Research Australia website as “www.msra.org”. The correct website is www.msra.org.au. Sorry for the confusion!)

____________

The Alexa Announcement 2:22

Introducing Matthew Miles & MS Research Australia 5:48

Study Shows MS Progresses Faster in African-Americans 6:46

Gilenya Shown To Be Effective in Delaying MS Progression & Disease Activity in Pediatric MS 8:00

MS Disease-Modifying Drugs May Lose Effectiveness As You Age 9:46

Interview with Dr. Matthew Miles 11:20

___________

LINKS
If your podcast app doesn't show these links, you'll find them in the show notes at www.RealTalkMS.com

The RealTalk MS Podcast Alexa Skill

STUDY: MS Progresses Faster in African-Americans

STUDY: Gilenya Effective in Delaying MS Progression & Disease Activity in Pediatric MS Patients

MS Disease-Modifying Therapies May Be Less Effective As You Age

MS Research Australia

Give RealTalk MS a Rating & Review

___________

Follow RealTalk MS on Twitter, @RealTalkMS_jon, and subscribe to our newsletter at our website, RealTalkMS.com.

RealTalk MS Episode 30
Guest: Dr. Matthew Miles
Hosted By: Jon Strum

Tags: MS, multiple sclerosis, Alexa, Matthew Miles, MS Research Australia, AAN, Gilenya